Why mTOR in Breast Cancer?
mTOR
mTOR is an intracellular kinase that controls the production of proteins by regulating mRNA translation in response to environmental cues.1,2 mTOR senses the availability of nutrients and consolidates this information with signaling from growth factors. Growth factor stimulation primarily stimulates mTOR signaling through the PI3K/Akt pathway, which is activated by growth factor receptors. Activated Akt mediates activation of mTOR.2,3
mTOR Regulates Cell Growth
Activated mTOR increases the rate of protein synthesis for certain mRNAs by activating proteins that direct DNA translation such as S6K1 and 4E-BP1.1 This results in increased production of proteins that stimulate cell growth and proliferation, cellular metabolism, and angiogenesis.
- Growth and proliferation: mTOR increases translation of proteins that drive cell growth and cell division, such as cyclin D1, and decreases translation of negative regulators of cell cycle progression3
- Cell metabolism: mTOR increases the surface expression of nutrient transporters.2 Increased availability of nutrients fulfills the energy, nutrient, and metabolic requirements for mTOR-activated cell growth and proliferation
- Angiogenesis: mTOR increases the translation of HIF (hypoxia inducible factor)-1α. The HIF transcription factors drive the expression of angiogenic growth factors such as VEGF, PDGF-β, and TGF-α4
mTOR acts as a central regulator that is frequently activated as a result of signaling from other proteins that are commonly mutated in cancer.2
mTOR supports cells with a supply of nutrients:
(1) mTOR activation increases the production of angiogenic growth factors; (2) increased blood vessel formation supplies the cellular environment with nutrients; (3) mTOR activation enhances nutrient uptake in the cell by increasing production of nutrient transporters; and (4) increased nutrient availability fulfills the metabolic needs for mTOR-mediated cell growth and proliferation.
References
- Fingar et al. Mol Cell Biol. 2004;24:200-216.
- Wullschleger et al. Cell. 2006;124:471-484.
- Hay et al. Genes Dev. 2004;18:1926-1945.
- Patel et al. Clin Cancer Res. 2006;12:7215-7220.